Nora E. Sarvetnick
#167,051
Most Influential Person Now
Nora E. Sarvetnick's AcademicInfluence.com Rankings
Nora E. Sarvetnickbiology Degrees
Biology
#13582
World Rank
#17136
Historical Rank
Immunology
#943
World Rank
#967
Historical Rank
Neuroscience
#2372
World Rank
#2437
Historical Rank
Download Badge
Biology
Nora E. Sarvetnick's Degrees
- PhD Immunology University of California, San Francisco
- Doctorate Medicine University of California, San Francisco
Why Is Nora E. Sarvetnick Influential?
(Suggest an Edit or Addition)Nora E. Sarvetnick's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Homeostatic Expansion of T Cells during Immune Insufficiency Generates Autoimmunity (2004) (720)
- Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. (1995) (631)
- Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma (1988) (463)
- Epithelial cell proliferation and islet neogenesis in IFN-g transgenic mice. (1993) (350)
- Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice (1996) (346)
- CD8(+) T cell-mediated spontaneous diabetes in neonatal mice. (1996) (345)
- Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ (1990) (336)
- Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice (1994) (324)
- Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes–prone mice (1996) (292)
- B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. (1998) (290)
- Local Delivery of Interleukin 4 by Retrovirus-Transduced T Lymphocytes Ameliorates Experimental Autoimmune Encephalomyelitis (1997) (279)
- Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. (1998) (274)
- CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. (1997) (273)
- Identification of MHC Class II-Restricted Peptide Ligands, Including a Glutamic Acid Decarboxylase 65 Sequence, that Stimulate Diabetogenic T Cells from Transgenic BDC2.5 Nonobese Diabetic Mice1 (2001) (230)
- Target cell defense prevents the development of diabetes after viral infection (2002) (213)
- Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. (1999) (206)
- Leptin accelerates autoimmune diabetes in female NOD mice. (2002) (204)
- TGF-beta1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. (1998) (203)
- IL-18 Directs Autoreactive T Cells and Promotes Autodestruction in the Central Nervous System Via Induction of IFN-γ by NK Cells1 (2000) (202)
- Interferon γ (IFN-γ) Is Necessary for the Genesis of Acetylcholine Receptor–induced Clinical Experimental Autoimmune Myasthenia gravis in Mice (1997) (197)
- Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse (2001) (196)
- Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans (1993) (184)
- Pancreatic expression of interferon-γ protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis (2000) (168)
- Transitional cells in the regenerating pancreas. (1994) (160)
- A Defect in Interleukin 12–Induced Activation and Interferon γ Secretion of Peripheral Natural Killer T Cells in Nonobese Diabetic Mice Suggests New Pathogenic Mechanisms for Insulin-Dependent Diabetes Mellitus (1999) (157)
- Innate immunity and autoimmunity: from self-protection to self-destruction. (2001) (155)
- The Incidence of Type-1 Diabetes in NOD Mice Is Modulated by Restricted Flora Not Germ-Free Conditions (2011) (148)
- Myasthenia gravis-like syndrome induced by expression of interferon gamma in the neuromuscular junction (1995) (147)
- Pancreatic expression of keratinocyte growth factor leads to differentiation of islet hepatocytes and proliferation of duct cells. (1999) (142)
- Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes. (2002) (139)
- T cell homeostasis in tolerance and immunity (2005) (137)
- Viruses, host responses, and autoimmunity (1999) (128)
- Hippo Signaling Regulates Pancreas Development through Inactivation of Yap (2012) (125)
- Pancreatic islet production of murine interleukin-10 does not inhibit immune-mediated tissue destruction. (1994) (124)
- IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity (1996) (123)
- Cytokines that regulate autoimmune responses. (1999) (121)
- Cytokines: promoters and dampeners of autoimmunity. (2002) (120)
- Mechanism underlying counterregulation of autoimmune diabetes by IL-4. (1997) (118)
- The stromal cell–derived factor-1α/CXCR4 ligand–receptor axis is critical for progenitor survival and migration in the pancreas (2003) (114)
- Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. (1998) (110)
- Up-Regulation of CD1d Expression Restores the Immunoregulatory Function of NKT Cells and Prevents Autoimmune Diabetes in Nonobese Diabetic Mice1 (2004) (109)
- Viruses, cytokines, antigens, and autoimmunity. (1996) (105)
- PDX-1 and Msx-2 expression in the regenerating and developing pancreas. (1999) (104)
- Loss of pancreatic islet tolerance induced by beta-cell expression of interferon-gamma. (1990) (104)
- Interferon-γ Protects against Herpes Simplex Virus Type 1-Mediated Neuronal Death (1997) (102)
- RNase L and Double-Stranded RNA-Dependent Protein Kinase Exert Complementary Roles in Islet Cell Defense during Coxsackievirus Infection1 (2005) (100)
- BMP4 Regulates Pancreatic Progenitor Cell Expansion through Id2* (2006) (99)
- Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse. (2003) (98)
- The Natural Killer Cell – Friend or Foe in Autoimmune Disease? (2002) (95)
- Interleukin-4 acts at the locus of the antigen-presenting dendritic cell to counter-regulate cytotoxic CD8+ T-cell responses (2001) (94)
- Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse. (1999) (93)
- Type 1 diabetes: role of intestinal microbiome in humans and mice (2011) (93)
- Transgenic mice expressing IFN-gamma in the retina develop inflammation of the eye and photoreceptor loss. (1994) (93)
- Inhibition of Autophagic Turnover in β-Cells by Fatty Acids and Glucose Leads to Apoptotic Cell Death* (2014) (90)
- A key role for ICAM-1 in generating effector cells mediating inflammatory responses (2001) (88)
- Lymphocyte proliferation in immune-mediated diseases. (2009) (86)
- CD4+ CD45RB low-density cells from untreated mice prevent acute allograft rejection. (1999) (85)
- Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus. (1999) (83)
- The Th2 cytokine IL-4 is not required for the progression of antibody-dependent autoimmune myasthenia gravis. (1998) (79)
- CCR4-bearing T cells participate in autoimmune diabetes. (2002) (75)
- Coxsackieviral-mediated diabetes: induction requires antigen-presenting cells and is accompanied by phagocytosis of beta cells. (2004) (74)
- A Mechanism for IL-10-Mediated Diabetes in the Nonobese Diabetic (NOD) Mouse: ICAM-1 Deficiency Blocks Accelerated Diabetes1 2 (2000) (71)
- Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes. (1999) (69)
- Vaccination with glutamic acid decarboxylase plasmid DNA protects mice from spontaneous autoimmune diabetes and B7/CD28 costimulation circumvents that protection. (2001) (68)
- The paradoxical effects of interleukin 10 in the immunoregulation of autoimmune diabetes. (1996) (66)
- Expression of ErbB receptors during pancreatic islet development and regrowth. (2000) (65)
- IL-10 impacts autoimmune diabetes via a CD8+ T cell pathway circumventing the requirement for CD4+ T and B lymphocytes. (1998) (64)
- α-Cell Neogenesis in an Animal Model of IDDM (1997) (63)
- Inhibition of activin signaling induces pancreatic epithelial cell expansion and diminishes terminal differentiation of pancreatic beta-cells. (2004) (63)
- Nonhomologous pairing in mice heterozygous for a t haplotype can produce recombinant chromosomes with duplications and deletions. (1986) (59)
- Predominant end-products of prophage Mu DNA transposition during the lytic cycle are replicon fusions. (1981) (59)
- Requirements for viral-mediated autoimmune diabetes: beta-cell damage and immune infiltration. (2001) (58)
- Interferon-gamma protects against herpes simplex virus type 1-mediated neuronal death. (1997) (57)
- Protection from Lethal Coxsackievirus-Induced Pancreatitis by Expression of Gamma Interferon (1999) (57)
- IL-21 Limits Peripheral Lymphocyte Numbers through T Cell Homeostatic Mechanisms (2008) (56)
- Islet-Specific Expression of IL-10 Promotes Diabetes in Nonobese Diabetic Mice Independent of Fas, Perforin, TNF Receptor-1, and TNF Receptor-2 Molecules1 (2000) (55)
- Transcription factor expression during pancreatic islet regeneration (2000) (55)
- Methamphetamine Administration Targets Multiple Immune Subsets and Induces Phenotypic Alterations Suggestive of Immunosuppression (2012) (54)
- A critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection. (2001) (54)
- Sensitization to self (virus) antigen by in situ expression of murine interferon-gamma. (1995) (53)
- Cytokine-mediated survival from lethal herpes simplex virus infection: role of programmed neuronal death. (1995) (52)
- Differential IL-21 signaling in APCs leads to disparate Th17 differentiation in diabetes-susceptible NOD and diabetes-resistant NOD.Idd3 mice. (2011) (51)
- Endocrine/Exocrine Intermediate Cells in Streptozotocin‐Treated Ins‐IFN‐γ Transgenic Mice (1997) (50)
- Granulocyte macrophage‐colony stimulating factor (GM‐CSF) recruits immune cells to the pancreas and delays STZ‐induced diabetes (2002) (48)
- IL-4 expression by grafts from transgenic mice fails to prevent allograft rejection. (1997) (48)
- Diabetogenic potential of human pathogens uncovered in experimentally permissive beta-cells. (2003) (45)
- Current understanding of the role of gut dysbiosis in type 1 diabetes (2019) (45)
- Growth factors in the regenerating pancreas of gamma-interferon transgenic mice. (1996) (45)
- Is pathogenic humoral autoimmunity a Th1 response? Lessons from (for) myasthenia gravis. (2000) (45)
- The pathogenesis of diabetes in the NOD mouse. (2004) (43)
- Altered RECQ Helicase Expression in Sporadic Primary Colorectal Cancers. (2013) (42)
- Tissue-specific expression of interleukin-4 induces extracellular matrix accumulation and extravasation of B cells. (1997) (41)
- Cytokines and autoimmunity: redundancy defines their complex nature. (2003) (41)
- B7-2 (CD86) Controls the Priming of Autoreactive CD4 T Cell Response against Pancreatic Islets1 (2004) (40)
- IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets. (2001) (40)
- IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse. (2000) (40)
- Th1 and Th2 Pancreatic Inflammation Differentially Affects Homing of Islet-Reactive CD4 Cells in Nonobese Diabetic Mice 1 (2003) (39)
- Endocrine/exocrine intermediate cells in streptozotocin-treated Ins-IFN-gamma transgenic mice. (1997) (39)
- Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice. (1999) (39)
- Control of the Autoimmune Response by Type 2 Nitric Oxide Synthase1 2 (2001) (38)
- Interferon-gamma and the sexual dimorphism of autoimmunity. (1990) (37)
- Ectopic expression of gamma interferon in the eye protects transgenic mice from intraocular herpes simplex virus type 1 infections (1994) (37)
- The effect of local production of cytokines in the pathogenesis of insulin-dependent diabetes mellitus. (1999) (37)
- Induction of vascular addressins and adhesion molecules in the pancreas of IFN-gamma transgenic mice. (1994) (37)
- FGFR3 Is a Negative Regulator of the Expansion of Pancreatic Epithelial Cells (2007) (35)
- Lack of β-catenin in early life induces abnormal glucose homeostasis in mice (2009) (35)
- Regeneration of pancreatic endocrine cells in interferon-gamma transgenic mice. (1992) (35)
- CCR2 and CCR5 chemokine receptors differentially influence the development of autoimmune diabetes in the NOD mouse (2010) (35)
- Identification and expansion of pancreatic stem/progenitor cells (2005) (34)
- Human homologs of two testes-expressed loci on mouse chromosome 17 map to opposite arms of chromosome 6. (1989) (34)
- Report from the 1st International NOD Mouse T-Cell Workshop and the follow-up mini-workshop. (2001) (33)
- CD8+ T Cell Tolerance in Nonobese Diabetic Mice Is Restored by Insulin-Dependent Diabetes Resistance Alleles1 (2005) (32)
- Development of cell markers for the identification and expansion of islet progenitor cells (2003) (32)
- Local production of IFN-gamma abrogates the intraocular immune privilege in transgenic mice and prevents the induction of ACAID. (1994) (31)
- The Role of NK Cells and NK Cell Receptors inAutoimmune Disease (2004) (30)
- A transgenic model for studying islet development. (1994) (30)
- Increased expression of IL-18 in the serum and islets of type 1 diabetics. (2015) (30)
- Exploiting Expression of Hippo Effector, Yap, for Expansion of Functional Islet Mass. (2015) (29)
- The target tissue in autoimmunity – an influential niche (2007) (28)
- Transgenic mice expressing IFN-gamma in pancreatic beta-cells are resistant to streptozotocin-induced diabetes. (1995) (28)
- Altered CD161bright CD8+ Mucosal Associated Invariant T (MAIT)-Like Cell Dynamics and Increased Differentiation States among Juvenile Type 1 Diabetics (2015) (28)
- Mechanisms of cytokine-mediated localized immunoprotection (1996) (27)
- Terminal Deoxynucleotidyltransferase Deficiency Decreases Autoimmune Disease in Diabetes-Prone Nonobese Diabetic Mice and Lupus-Prone MRL-Faslpr Mice1 (2004) (26)
- Nodal and lefty signaling regulates the growth of pancreatic cells (2008) (26)
- TLR signaling controls lethal encephalitis in WNV-infected brain (2014) (25)
- Differences in Suppressor of Cytokine Signaling-1 (SOCS-1) Expressing Islet Allograft Destruction in Normal BALB/c and Spontaneously-Diabetic NOD Recipient Mice (2005) (25)
- Upregulation of activin signaling in experimental colitis. (2009) (25)
- STAT4/6-dependent differential regulation of chemokine receptors. (2006) (24)
- Transforming growth factor-beta fails to inhibit allograft rejection or virus-induced autoimmune diabetes in transgenic mice. (1996) (24)
- Necrotizing myopathy induced by overexpression of interferon‐γ in transgenic mice (1999) (24)
- The microbial product lipopolysaccharide confers diabetogenic potential on the T cell repertoire of BDC2.5/NOD mice: implications for the etiology of autoimmune diabetes. (2000) (23)
- Coxsackievirus-mediated hyperglycemia is enhanced by reinfection and this occurs independent of T cells. (2003) (23)
- alpha-Cell neogenesis in an animal model of IDDM. (1997) (23)
- Resistance of the target islet tissue to autoimmune destruction contributes to genetic susceptibility in Type 1 diabetes (2007) (22)
- Pancreatic growth and regeneration (1997) (22)
- Organ-specific autoimmunity. (1997) (22)
- Transforming growth factor-beta inhibits coxsackievirus-mediated autoimmune myocarditis. (2006) (22)
- FGFR3 contributes to intestinal crypt cell growth arrest (2008) (20)
- Interleukin (IL)-18 Binding Protein Deficiency Disrupts Natural Killer Cell Maturation and Diminishes Circulating IL-18 (2017) (19)
- Postnatal anti-interferon-γ treatment prevents pancreatic inflammation in transgenic mice with β-cell expression of interferon-γ (1994) (18)
- Cytokines and Autoimmune Diseases (2001) (17)
- TGF-β superfamily member Nodal stimulates human β-cell proliferation while maintaining cellular viability. (2013) (17)
- IL-18 is required for self-reactive T cell expansion in NOD mice. (2011) (17)
- Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice. (2009) (17)
- Genetic control of diabetes mellitus (1992) (16)
- Transgenic/knockout mice--tools to study autoimmunity. (1995) (16)
- Necrotizing myopathy induced by overexpression of interferon-gamma in transgenic mice. (1999) (16)
- Transgenic expression of interleukin 10 in the pancreas renders resistant mice susceptible to low dose streptozotocin-induced diabetes. (1996) (16)
- A mouse chromosome 17 gene encodes a testes-specific transcript with unusual properties (1989) (15)
- B7-1 mediated costimulation regulates pancreatic autoimmunity. (2007) (15)
- Increased islet antigen presentation leads to type‐1 diabetes in mice with autoimmune susceptibility (2004) (15)
- Treatment of IFN-γ Transgenic Mice With Anti–IFN-γ Reveals the Remodeling Capacity of the Adult Pancreas (1995) (14)
- Growth factor-induced signaling of the pancreatic epithelium. (2005) (14)
- Mechanism of bacteriophage Mu DNA transposition. (1981) (14)
- IFN-gamma, IGIF, and IDDM. (1997) (14)
- Beta-cell specific expression of suppressor of cytokine signaling-1 (SOCS-1) delays islet allograft rejection by down-regulating Interferon Regulatory Factor-1 (IRF-1) signaling. (2011) (14)
- Coordinated Induction of Antimicrobial Response Factors in Systemic Lupus Erythematosus (2019) (13)
- PYY in the expanding pancreatic epithelium (2006) (13)
- Peptides from common viral and bacterial pathogens can efficiently activate diabetogenic T-cells. (2004) (13)
- Effect on insulin production sorting and secretion by major histocompatibility complex class II gene expression in the pancreatic beta-cell of transgenic mice. (1992) (13)
- Abnormal T Cell Frequencies, Including Cytomegalovirus-Associated Expansions, Distinguish Seroconverted Subjects at Risk for Type 1 Diabetes (2018) (12)
- WS6 induces both alpha and beta cell proliferation without affecting differentiation or viability. (2015) (12)
- B7-2 Regulates Survival, Phenotype, and Function of APCs1 (2007) (12)
- Cholecystokinin expression in the developing and regenerating pancreas and intestine. (2001) (12)
- Human Islet Response to Selected Type 1 Diabetes-Associated Bacteria: A Transcriptome-Based Study (2019) (12)
- CD28⁻ CD8⁺ T cells are significantly reduced and correlate with disease duration in juveniles with type 1 diabetes. (2014) (11)
- Differential impact of T cell repertoire diversity in diabetes-prone or -resistant IL-10 transgenic mice. (1999) (11)
- Pancreatic IL-10 induces diabetes in NOD.B6 Idd3 Idd10 mice. (1997) (10)
- Heightened Levels of Antimicrobial Response Factors in Patients With Rheumatoid Arthritis (2020) (10)
- Peptide specific amelioration of T cell mediated pathogenesis in murine type 1 diabetes. (2004) (10)
- Costimulation and pancreatic autoimmunity: the PD-1/PD-L conundrum. (2006) (10)
- Methods for Detection of Apoptosis in the CNS (1997) (10)
- Inflammatory destruction of pancreatic beta cells in gamma-interferon transgenic mice. (1989) (9)
- ID2 promotes the expansion and survival of growth-arrested pancreatic beta cells (2007) (9)
- Expression of Id1 in adult, regenerating and developing pancreas (2007) (9)
- Etiology of autoimmunity (2000) (9)
- The role of infiltrating macrophages in islet destruction and regrowth in a transgenic model. (1995) (8)
- Induction of antigen specific peripheral humoral tolerance to cardiac myosin does not prevent CB3-mediated autoimmune myocarditis. (2005) (8)
- The role of cytokines in autoimmunity. (1999) (8)
- TNF-α Receptor 1 (p55) on Islets Is Necessary for the Expression of LIGHT on Diabetogenic T Cells (2001) (8)
- Treatment of IFN-gamma transgenic mice with anti-IFN-gamma reveals the remodeling capacity of the adult pancreas. (1995) (8)
- Transgenes in autoimmunity. (1992) (8)
- Functional effects of transgenic expression of cholera toxin in pancreatic beta-cells (1993) (7)
- TNF-alpha receptor 1 (p55) on islets is necessary for the expression of LIGHT on diabetogenic T cells. (2001) (6)
- Transgenic mice for the study of diabetes mellitus (1991) (6)
- Transgenic mouse models for growth factor studies. (1991) (6)
- Postnatal anti-interferon-gamma treatment prevents pancreatic inflammation in transgenic mice with beta-cell expression of interferon-gamma. (1994) (6)
- Cytokines and IDDM: implications for etiology and therapy. (1998) (5)
- Protective effects of interferon-gamma in intraocular herpes simplex type 1 infection do not depend on major histocompatibility complex class I or class II expression. (1995) (5)
- Confirmation and Identification of Biomarkers Implicating Environmental Triggers in the Pathogenesis of Type 1 Diabetes (2020) (5)
- Transgenic models of diabetes. (1990) (5)
- Autoimmune Myasthenia Gravis the Progression of Antibody-Dependent The Th 2 Cytokine IL-4 Is Not Required for and (1998) (5)
- Increasing the chemical potential of the germ-line antibody repertoire. (1993) (5)
- Ocular production of interferon-gamma and lack of major histocompatibility complex molecules induce immunological changes in the intraocular environment. (1996) (5)
- Islet regeneration in IFNgamma transgenic mice. (1997) (5)
- Interleukin-4 secretion by the allograft fails to affect the allograft-specific interleukin-4 response in vitro. (1999) (4)
- Autoimmunity mediated by innate immune effector cells (2001) (4)
- The influence of cytokines on the central nervous system of transgenic mice. (1996) (4)
- Fetal exposure to interferon-gamma leads to induction of antigen-presenting molecules and leukocyte recruitment. (1997) (3)
- Immunomodulation of the Anti-Islet CD8 T Cell Response by B7-2 (2007) (3)
- H-2D End Confers Dominant Protection from IL-10-Mediated Acceleration of Autoimmune Diabetes in the Nonobese Diabetic Mouse1 (2001) (3)
- Autoimmunity a bias from tolerance to immunity. (1997) (3)
- Receptor-1 , and TNF Receptor-2 Molecules Independent of Fas , Perforin , TNF Diabetes in Nonobese Diabetic Mice Islet-Specific Expression of IL-10 Promotes (2000) (3)
- Epithelial progenitor 1, a novel factor associated with epithelial cell growth and differentiation (2010) (2)
- MiceIslet-Reactive CD4 Cells in Nonobese Diabetic Differentially Affects Homing of Th1 and Th2 Pancreatic Inflammation (2003) (1)
- This information is current as during Coxsackievirus Infection Complementary Roles in Islet Cell Defense RNA-Dependent Protein Kinase Exert RNase L and Double-Stranded Williams (2005) (1)
- Strong attraction may be dangerous: parameters for the development of long term commitment. (2004) (1)
- From the 1 st International NOD Mouse T-Cell Workshop and the Follow-Up Mini-Workshop (2001) (1)
- Transgenic Expression of IFN-γ in the Eye as a Model for Studying Ocular Inflammatory Disease (1996) (1)
- Induction of Autoimmune Diabetes Multiple Chemokines and Promote Rapid Islet-Specific Th 1 , But Not Th 2 , Cells Secrete (1999) (1)
- CD 4 1 CD 45 RB Low-Density Cells from Untreated Mice Prevent Acute Allograft Rejection 1 (1999) (1)
- Pancreatic Islets Autoreactive CD4 T Cell Response against B7-2 (CD86) Controls the Priming of (2004) (0)
- Tyrosine kinase receptors are crucial for normal β-cell development and function (2007) (0)
- Changes in Leukocyte Populations Among Children Receiving a Follow‐on Cow's Milk‐Based Formula Containing Beta‐Glucan (2013) (0)
- Heightened levels of antimicrobial response factors in patients with systemic lupus erythematosus (2019) (0)
- IL-10 Transgenic Mice (1995) (0)
- MARKERS IN EXPANSION OF REGENERATING & EARLY POSTNATAL PANCREAS (2008) (0)
- W1572 Involvement of Nodal and Lefty Signaling in Intestinal Crypt Cell Growth (2009) (0)
- Murine Transgenic Models of IDDM (1994) (0)
- 21 Pancreatic Stem Cells (2001) (0)
- Islet Tolerance in Humans and Transgenic Mice (1993) (0)
- Short communication Protective effects of interferon-gamma in intraocular herpes simplex type I infection do not depend on major histocompatibility complex class I or class I1 expression (1995) (0)
- Diabetogenic T Cells from Transgenic Decarboxylase 65 Sequence, that Stimulate Peptide Ligands, Including a Glutamic Acid Identification of MHC Class II-Restricted (2013) (0)
- Cytokine Transgenic Mice and Autoimmunity (1996) (0)
- Regulatory and counterregulatory effectors in IDDM (2009) (0)
- The Role of IL‐21 In Lymphopenia‐Induced Homeostatic Proliferation (2008) (0)
- Nonobese Diabetic Mice Cells and Prevents Autoimmune Diabetes in the Immunoregulatory Function of NKT Up-Regulation of CD 1 d Expression Restores (2004) (0)
- Anti-human Interleukin(IL)-4 Clone 8D4-8 Cross-Reacts With Myosin-9 Associated With Apoptotic Cells and Should Not Be Used for Flow Cytometry Applications Querying IL-4 Expression (2019) (0)
- Type 2 Nitric Oxide Synthase Control of the Autoimmune Response by (2001) (0)
- MOTOR END PLATE DESTRUCTION AND INFLAMMATORY MYOPATHY IN A TRANSGENIC MOUSE OVEREXPRESSING INTERFERON GAMMA: 184 (1995) (0)
- 1751-P: Human Islet Response to Selected Type 1 Diabetes Associated Bacteria (2019) (0)
- Autoimmunity: 2000 and Beyond, Newport Beach, California, February 11–13, 2000 (2004) (0)
- Transposable Genetic Elements: The Mu Paradigm (1980) (0)
- 11 – Immunological Studies Utilizing Cytokine Transgenic Mice (1994) (0)
- Pancreatic islet regeneration in a lymphokine-induced model (1997) (0)
- The role of PD-1/PD-L and B7/CD28 pathways in modulating anti-islet immune responses (B94) (2007) (0)
- Interleukin‐18 regulates T cell differentiation and the composition of peripheral T cell subsets (2008) (0)
- Interferon ~ ( IFN-~ ) Is Necessary for the Genesis o f Acety lchol ine (2003) (0)
- Transgenic animal models: Insights into the regulation and maintenance of islet cell mass (1996) (0)
- Nodal and Lefty signaling regulates the growth of pancreatic cells (2008) (0)
- Insulin-Dependent Diabetes Mellitus T Cell-Mediated + Cytotoxic Pathways in CD 8 Perforin / Granzyme Versus Fas / Fas Ligand Comparing the Relative Role of Ko , (1999) (0)
- The Nucleotide‐binding Oligomerisation Domain Protein 1 in T cells Modulates TCR Mediated Responses in the Thymus and Periphery (2008) (0)
- Pancreatic Expression o f Interleukin-4 Abrogates Insulitis and (2003) (0)
- Inflammatory Destruction of Pancreatic Islets in Interferon Gamma Transgenic Mice (1989) (0)
- W1163 Activin Signaling in Experimental Colitis (2008) (0)
- Inflammation and decreased immunoregulation characterize the leptin receptor deficient (db/db) mouse model of type II diabetes. (173.12) (2012) (0)
- Impact of IL-18 on Dendritic Cells in a Murine Model of Inflammatory Bowel Disease (2012) (0)
- Toll‐like receptors are critical for protection against West Nile virus infection (2008) (0)
- Changes in Leukocyte Populations among Children Receiving a Follow‐on Cow's Milk‐Based Formula Containing Lactobacillus rhamnosus GG (2013) (0)
- CONSTITUTIVE EXPRESSION OF SUPPRESSOR OF CYTOKINE SIGNALING-1 (SOCS-1) IN PANCREATIC ISLETS DELAYS ISLET ALLOGRAFT REJECTION. (2004) (0)
- Frequencies of CD8 and DN MAIT Cells Among Children Diagnosed With Type 1 Diabetes Are Similar to Age-Matched Controls (2021) (0)
- Is pathogenic humoral autoimmunity a Thl response? (multiple letters) [2] (2000) (0)
- Autoimmunity: 2000 and Beyond, Newport Beach, California, February 11–13, 2000 (2004) (0)
- ISLET CELL DESTRUCTION AND GROWTH STUDIED IN TRANSGENIC ANIMAL MODELS (1993) (0)
- Function of APCs B7-2 Regulates Survival, Phenotype, and (0)
- Delayed Activation of Innate Immunity in Murine Model of Diabetic Wounds: Initiating An Aberrant Inflammatory Response (2012) (0)
- Interleukin-10 precipitates disease in nonobese diabetic mice via a CD8+ T cell-dependent, CD4+ T cell-independent pathway (1998) (0)
- Transgenic mouse models of insulin dependent diabetes mellitus (1990) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Nora E. Sarvetnick?
Nora E. Sarvetnick is affiliated with the following schools:
